Literature DB >> 20444475

Microvascular response to shock wave application in striated skin muscle.

Maurizio Calcagni1, Fanfan Chen, Dominik C Högger, Nicole Lindenblatt, Marius Keel, Pietro Giovanoli, Claudio Contaldo.   

Abstract

BACKGROUND: This study aims to quantify by intravital microscopy the microhemodynamic response after extracorporeal shock wave application (ESWA) to the physiologic microcirculation of the mouse dorsal skinfold chamber.
MATERIALS AND METHODS: ESWA was carried out using an electrohydraulic shock wave source. Two different shock wave doses of 500 and 1000 pulses at an energy flux rate of 0.08 mJ/mm(2) and a frequency of 4 Hz were compared with sham-operated animals. Microcirculatory analyses were performed at baseline (BL) and during a 3 d observation period after ESWA. The expression of caspase-3 (casp-3), proliferating cell nuclear antibody (PCNA), von Willebrand factor (vWF), and endothelial nitric oxide synthase (eNOS) were analyzed semiquantitatively by immunohistochemistry.
RESULTS: ESWA provoked a significant and persistent increase of functional capillary density (FCD) throughout the observation period, reaching a maximum (140% ± 5% of BL, P < 0.05 versus sham) after 1 d when animals were treated with 1000 pulses. ESWA induced a slight increase of leukocyte rolling (∼2- to ∼3.5-fold, P < 0.05) and leukocyte adherence (∼1.5- to ∼2-fold, P < 0.05) to the endothelial lining of postcapillary venules. One day following ESWA, we observed enhanced expression of casp-3 (∼3- to ∼4-fold), PCNA (∼9- to ∼14-fold), vWF (∼11- to ∼14-fold), and eNOS (∼3-fold), all P < 0.05.
CONCLUSION: This study shows that ESWA provokes a favorable persistent increase of patent capillaries, however accompanied by a transient and slight inflammatory response but also by dose-dependant apoptotic cell death. Our data suggest that ESWA might represent a noninvasive biomechanical tool to treat critically perfused and endangered tissues, but certainly warrants further investigation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20444475     DOI: 10.1016/j.jss.2009.12.011

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  4 in total

1.  Shock wave therapy for systemic sclerosis.

Authors:  L Belloli; M Cugno; M C D'Agostino; N Ughi; A Tedeschi; S Respizzi; B Marasini
Journal:  Rheumatol Int       Date:  2011-12-25       Impact factor: 2.631

2.  Dose-related effect of extracorporeal shock wave therapy for plantar fasciitis.

Authors:  Su-Jin Lee; Jung-Ho Kang; Ja-Young Kim; Jin-Hong Kim; Seo-Ra Yoon; Kwang-Ik Jung
Journal:  Ann Rehabil Med       Date:  2013-06-30

3.  In Vivo Modulation of Angiogenesis and Immune Response on a Collagen Matrix via Extracorporeal Shockwaves.

Authors:  Diana Heimes; Nadine Wiesmann; Jonas Eckrich; Juergen Brieger; Stefan Mattyasovszky; Peter Proff; Manuel Weber; James Deschner; Bilal Al-Nawas; Peer W Kämmerer
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

4.  Intracerebroventricular infusion of donepezil prevents cardiac remodeling and improves the prognosis of chronic heart failure rats.

Authors:  Meihua Li; Can Zheng; Toru Kawada; Masashi Inagaki; Kazunori Uemura; Masaru Sugimachi
Journal:  J Physiol Sci       Date:  2020-02-17       Impact factor: 2.781

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.